세계의 소 유방염 치료 시스템 시장(2024-2028년)

The bovine mastitis treatment system market is forecasted to grow by USD 551.33 mn during 2023-2028, accelerating at a CAGR of 5.34% during the forecast period. The report on the bovine mastitis treatment system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of mastitis, growing emphasis on food safety and quality, and integration of PLF technologies with bovine mastitis treatment systems.

Technavio's bovine mastitis treatment system market is segmented as below:

By Product

• Antibiotics
• Others

By Route Of Administration

• Intramammary
• Systemic

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence and adoption of automated detection systems and precision medicine as one of the prime reasons driving the bovine mastitis treatment system market growth during the next few years. Also, rising adoption of non-antibiotic therapies for mastitis management and growing awareness about animal welfare will lead to sizable demand in the market.

The report on the bovine mastitis treatment system market covers the following areas:

• Bovine mastitis treatment system market sizing
• Bovine mastitis treatment system market forecast
• Bovine mastitis treatment system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bovine mastitis treatment system market vendors that include Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., HIPRA S A, Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and Thermo Fisher Scientific Inc.. Also, the bovine mastitis treatment system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global bovine mastitis treatment system market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global bovine mastitis treatment system market 2018 - 2022 ($ million)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 Route of Administration Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Antibiotics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
• 6.4 Others - Market size and forecast 2023-2028
• Exhibit 38: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration

• 7.1 Market segments
• Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)
• 7.2 Comparison by Route of Administration
• Exhibit 46: Chart on Comparison by Route of Administration
• Exhibit 47: Data Table on Comparison by Route of Administration
• 7.3 Intramammary - Market size and forecast 2023-2028
• Exhibit 48: Chart on Intramammary - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Intramammary - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Intramammary - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Intramammary - Year-over-year growth 2023-2028 (%)
• 7.4 Systemic - Market size and forecast 2023-2028
• Exhibit 52: Chart on Systemic - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Systemic - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Systemic - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Systemic - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Route of Administration
• Exhibit 56: Market opportunity by Route of Administration ($ million)
• Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 India - Market size and forecast 2023-2028
• Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 France - Market size and forecast 2023-2028
• Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 Advanced Animal Diagnostics
• Exhibit 107: Advanced Animal Diagnostics - Overview
• Exhibit 108: Advanced Animal Diagnostics - Product / Service
• Exhibit 109: Advanced Animal Diagnostics - Key offerings
• 12.4 Bio-Vet
• Exhibit 110: Bio-Vet - Overview
• Exhibit 111: Bio-Vet - Product / Service
• Exhibit 112: Bio-Vet - Key offerings
• 12.5 Boehringer Ingelheim International GmbH
• Exhibit 113: Boehringer Ingelheim International GmbH - Overview
• Exhibit 114: Boehringer Ingelheim International GmbH - Business segments
• Exhibit 115: Boehringer Ingelheim International GmbH - Key news
• Exhibit 116: Boehringer Ingelheim International GmbH - Key offerings
• Exhibit 117: Boehringer Ingelheim International GmbH - Segment focus
• 12.6 Ceva Sante Animale
• Exhibit 118: Ceva Sante Animale - Overview
• Exhibit 119: Ceva Sante Animale - Product / Service
• Exhibit 120: Ceva Sante Animale - Key offerings
• 12.7 Elanco Animal Health Inc.
• Exhibit 121: Elanco Animal Health Inc. - Overview
• Exhibit 122: Elanco Animal Health Inc. - Product / Service
• Exhibit 123: Elanco Animal Health Inc. - Key offerings
• 12.8 Endovac Animal Health
• Exhibit 124: Endovac Animal Health - Overview
• Exhibit 125: Endovac Animal Health - Product / Service
• Exhibit 126: Endovac Animal Health - Key offerings
• 12.9 HIPRA S A
• Exhibit 127: HIPRA S A - Overview
• Exhibit 128: HIPRA S A - Product / Service
• Exhibit 129: HIPRA S A - Key offerings
• 12.10 ImmuCell Corp.
• Exhibit 130: ImmuCell Corp. - Overview
• Exhibit 131: ImmuCell Corp. - Business segments
• Exhibit 132: ImmuCell Corp. - Key offerings
• Exhibit 133: ImmuCell Corp. - Segment focus
• 12.11 Merck KGaA
• Exhibit 134: Merck KGaA - Overview
• Exhibit 135: Merck KGaA - Business segments
• Exhibit 136: Merck KGaA - Key news
• Exhibit 137: Merck KGaA - Key offerings
• Exhibit 138: Merck KGaA - Segment focus
• 12.12 Nimrod Veterinary Products Ltd.
• Exhibit 139: Nimrod Veterinary Products Ltd. - Overview
• Exhibit 140: Nimrod Veterinary Products Ltd. - Product / Service
• Exhibit 141: Nimrod Veterinary Products Ltd. - Key offerings
• 12.13 Norbrook Laboratories Ltd.
• Exhibit 142: Norbrook Laboratories Ltd. - Overview
• Exhibit 143: Norbrook Laboratories Ltd. - Product / Service
• Exhibit 144: Norbrook Laboratories Ltd. - Key offerings
• 12.14 Thermo Fisher Scientific Inc.
• Exhibit 145: Thermo Fisher Scientific Inc. - Overview
• Exhibit 146: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 147: Thermo Fisher Scientific Inc. - Key news
• Exhibit 148: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 149: Thermo Fisher Scientific Inc. - Segment focus
• 12.15 Vetoquinol SA
• Exhibit 150: Vetoquinol SA - Overview
• Exhibit 151: Vetoquinol SA - Business segments
• Exhibit 152: Vetoquinol SA - Key news
• Exhibit 153: Vetoquinol SA - Key offerings
• Exhibit 154: Vetoquinol SA - Segment focus
• 12.16 Virbac Group
• Exhibit 155: Virbac Group - Overview
• Exhibit 156: Virbac Group - Business segments
• Exhibit 157: Virbac Group - Key news
• Exhibit 158: Virbac Group - Key offerings
• Exhibit 159: Virbac Group - Segment focus
• 12.17 Zoetis Inc.
• Exhibit 160: Zoetis Inc. - Overview
• Exhibit 161: Zoetis Inc. - Business segments
• Exhibit 162: Zoetis Inc. - Key news
• Exhibit 163: Zoetis Inc. - Key offerings
• Exhibit 164: Zoetis Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 165: Inclusions checklist
• Exhibit 166: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 167: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 168: Research methodology
• Exhibit 169: Validation techniques employed for market sizing
• Exhibit 170: Information sources
• 13.5 List of abbreviations
• Exhibit 171: List of abbreviations